View Financial HealthChemlite Innovation Berhad 배당 및 자사주 매입배당 기준 점검 2/6Chemlite Innovation Berhad 수익으로 충분히 충당되는 현재 수익률 3.5% 보유한 배당금 지급 회사입니다.핵심 정보3.5%배당 수익률-0.2%자사주 매입 수익률총 주주 수익률3.3%미래 배당 수익률n/a배당 성장률-29.7%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향36%최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesNew Risk • May 25New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. Dividend per share is over 12x cash flows per share. Dividend yield: 3.1% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (dividend per share is over 12x cash flows per share). Profit margins are more than 30% lower than last year (15% net profit margin). Market cap is less than US$100m (RM138.0m market cap, or US$34.8m).Reported Earnings • May 20First quarter 2026 earnings released: EPS: RM0.002 (vs RM0.001 in 1Q 2025)First quarter 2026 results: EPS: RM0.002 (up from RM0.001 in 1Q 2025). Revenue: RM8.43m (down 11% from 1Q 2025). Net income: RM1.06m (up 91% from 1Q 2025). Profit margin: 13% (up from 5.9% in 1Q 2025). The increase in margin was driven by lower expenses.분석 기사 • May 05Weak Statutory Earnings May Not Tell The Whole Story For Chemlite Innovation Berhad (KLSE:CLITE)The market rallied behind Chemlite Innovation Berhad's ( KLSE:CLITE ) stock, leading do a rise in the share price after...공시 • Apr 22Chemlite Innovation Berhad, Annual General Meeting, May 15, 2026Chemlite Innovation Berhad, Annual General Meeting, May 15, 2026, at 10:30 Singapore Standard Time. Location: iconic 1 & 2, iconic hotel, 71 jalan icon city, icon city, 14000 bukit mertajam, penang, MalaysiaReported Earnings • Mar 01Full year 2025 earnings released: EPS: RM0.01 (vs RM0.036 in FY 2024)Full year 2025 results: EPS: RM0.01 (down from RM0.036 in FY 2024). Revenue: RM41.6m (up 22% from FY 2024). Net income: RM5.42m (down 42% from FY 2024). Profit margin: 13% (down from 27% in FY 2024). The decrease in margin was driven by higher expenses.분석 기사 • Nov 27Here's Why Chemlite Innovation Berhad (KLSE:CLITE) Has A Meaningful Debt BurdenWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Reported Earnings • Nov 25Third quarter 2025 earnings released: EPS: RM0.002 (vs RM0.005 in 3Q 2024)Third quarter 2025 results: EPS: RM0.002 (down from RM0.005 in 3Q 2024). Revenue: RM10.3m (up 20% from 3Q 2024). Net income: RM1.14m (down 55% from 3Q 2024). Profit margin: 11% (down from 29% in 3Q 2024). The decrease in margin was driven by higher expenses.분석 기사 • Sep 05Weak Statutory Earnings May Not Tell The Whole Story For Chemlite Innovation Berhad (KLSE:CLITE)Chemlite Innovation Berhad's ( KLSE:CLITE ) stock showed strength, with investors undeterred by its weak earnings...Reported Earnings • Aug 31Second quarter 2025 earnings released: EPS: RM0.002 (vs RM0.062 in 2Q 2024)Second quarter 2025 results: EPS: RM0.002 (down from RM0.062 in 2Q 2024). Revenue: RM8.91m (up 4.9% from 2Q 2024). Net income: RM821.0k (down 61% from 2Q 2024). Profit margin: 9.2% (down from 25% in 2Q 2024). The decrease in margin was driven by higher expenses.분석 기사 • Jul 11Is Chemlite Innovation Berhad (KLSE:CLITE) A Risky Investment?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Reported Earnings • Jun 03First quarter 2025 earnings released: EPS: RM0.001 (vs RM0.062 in 1Q 2024)First quarter 2025 results: EPS: RM0.001 (down from RM0.062 in 1Q 2024). Revenue: RM9.42m (up 11% from 1Q 2024). Net income: RM552.0k (down 74% from 1Q 2024). Profit margin: 5.9% (down from 25% in 1Q 2024). The decrease in margin was driven by higher expenses.공시 • Apr 29Chemlite Innovation Berhad, Annual General Meeting, May 29, 2025Chemlite Innovation Berhad, Annual General Meeting, May 29, 2025, at 10:30 Singapore Standard Time. Location: iconic 1 & 2, iconic hotel, 71 jalan icon city, icon city, 14000 bukit mertajam, penang, MalaysiaBoard Change • Mar 26High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. COO & Executive Director Chee Heng is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 이제 막 배당금 지급을 시작했기 때문에 CLITE 의 배당금 지급이 안정적인지 여부를 판단하기에는 너무 이릅니다.배당금 증가: 이제 막 배당금 지급을 시작했기 때문에 CLITE 의 배당금 지급액이 늘어나고 있는지 판단하기에는 너무 이릅니다.배당 수익률 vs 시장Chemlite Innovation Berhad 배당 수익률 vs 시장CLITE의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (CLITE)3.5%시장 하위 25% (MY)2.0%시장 상위 25% (MY)5.4%업계 평균 (Metals and Mining)1.7%분석가 예측 (CLITE) (최대 3년)n/a주목할만한 배당금: CLITE 의 배당금( 3.5% )은 MY 시장에서 배당금 지급자의 하위 25%( 2.05% )보다 높습니다.고배당: CLITE 의 배당금( 3.5% )은 MY 시장에서 배당금 지급자의 상위 25%( 5.39% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 합리적으로 낮은 지불 비율 ( 35.5% )로 CLITE 의 배당금 지급은 수익으로 충분히 충당됩니다.주주 현금 배당현금 흐름 범위: 현금 지급 비율 ( 1299.2% )이 높기 때문에 CLITE 의 배당금 지급은 현금 흐름으로 잘 충당되지 않습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YMY 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/25 02:42종가2026/06/25 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Chemlite Innovation Berhad는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
New Risk • May 25New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. Dividend per share is over 12x cash flows per share. Dividend yield: 3.1% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (dividend per share is over 12x cash flows per share). Profit margins are more than 30% lower than last year (15% net profit margin). Market cap is less than US$100m (RM138.0m market cap, or US$34.8m).
Reported Earnings • May 20First quarter 2026 earnings released: EPS: RM0.002 (vs RM0.001 in 1Q 2025)First quarter 2026 results: EPS: RM0.002 (up from RM0.001 in 1Q 2025). Revenue: RM8.43m (down 11% from 1Q 2025). Net income: RM1.06m (up 91% from 1Q 2025). Profit margin: 13% (up from 5.9% in 1Q 2025). The increase in margin was driven by lower expenses.
분석 기사 • May 05Weak Statutory Earnings May Not Tell The Whole Story For Chemlite Innovation Berhad (KLSE:CLITE)The market rallied behind Chemlite Innovation Berhad's ( KLSE:CLITE ) stock, leading do a rise in the share price after...
공시 • Apr 22Chemlite Innovation Berhad, Annual General Meeting, May 15, 2026Chemlite Innovation Berhad, Annual General Meeting, May 15, 2026, at 10:30 Singapore Standard Time. Location: iconic 1 & 2, iconic hotel, 71 jalan icon city, icon city, 14000 bukit mertajam, penang, Malaysia
Reported Earnings • Mar 01Full year 2025 earnings released: EPS: RM0.01 (vs RM0.036 in FY 2024)Full year 2025 results: EPS: RM0.01 (down from RM0.036 in FY 2024). Revenue: RM41.6m (up 22% from FY 2024). Net income: RM5.42m (down 42% from FY 2024). Profit margin: 13% (down from 27% in FY 2024). The decrease in margin was driven by higher expenses.
분석 기사 • Nov 27Here's Why Chemlite Innovation Berhad (KLSE:CLITE) Has A Meaningful Debt BurdenWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Reported Earnings • Nov 25Third quarter 2025 earnings released: EPS: RM0.002 (vs RM0.005 in 3Q 2024)Third quarter 2025 results: EPS: RM0.002 (down from RM0.005 in 3Q 2024). Revenue: RM10.3m (up 20% from 3Q 2024). Net income: RM1.14m (down 55% from 3Q 2024). Profit margin: 11% (down from 29% in 3Q 2024). The decrease in margin was driven by higher expenses.
분석 기사 • Sep 05Weak Statutory Earnings May Not Tell The Whole Story For Chemlite Innovation Berhad (KLSE:CLITE)Chemlite Innovation Berhad's ( KLSE:CLITE ) stock showed strength, with investors undeterred by its weak earnings...
Reported Earnings • Aug 31Second quarter 2025 earnings released: EPS: RM0.002 (vs RM0.062 in 2Q 2024)Second quarter 2025 results: EPS: RM0.002 (down from RM0.062 in 2Q 2024). Revenue: RM8.91m (up 4.9% from 2Q 2024). Net income: RM821.0k (down 61% from 2Q 2024). Profit margin: 9.2% (down from 25% in 2Q 2024). The decrease in margin was driven by higher expenses.
분석 기사 • Jul 11Is Chemlite Innovation Berhad (KLSE:CLITE) A Risky Investment?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Reported Earnings • Jun 03First quarter 2025 earnings released: EPS: RM0.001 (vs RM0.062 in 1Q 2024)First quarter 2025 results: EPS: RM0.001 (down from RM0.062 in 1Q 2024). Revenue: RM9.42m (up 11% from 1Q 2024). Net income: RM552.0k (down 74% from 1Q 2024). Profit margin: 5.9% (down from 25% in 1Q 2024). The decrease in margin was driven by higher expenses.
공시 • Apr 29Chemlite Innovation Berhad, Annual General Meeting, May 29, 2025Chemlite Innovation Berhad, Annual General Meeting, May 29, 2025, at 10:30 Singapore Standard Time. Location: iconic 1 & 2, iconic hotel, 71 jalan icon city, icon city, 14000 bukit mertajam, penang, Malaysia
Board Change • Mar 26High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. COO & Executive Director Chee Heng is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.